ISSN 2054-7323
Now Accepting Submissions
..................................................................................
OA Stem Cells is a multidisciplinary open access 'peer reviewed' journal that publishes basic and clinical research concerning all aspects of stem cell research:
Embryonic Stem Cells
Tissue-Specific Stem Cells
Cancer Stem Cells
Developmental Studies
Stem Cell Genomes
Translational Research
OA Stem Cells is committed to publishing high quality 'peer reviewed' manuscripts that illustrate the most important and 'cutting edge' developments in all areas of stem cell research.
We will facilitate article submission, rapid article quality assurance through 'peer review', article formatting and processing to a final product which will allow high visibility, impact and provoke debate.
This journal has adopted the following models:
- Creative Commons Attribution License (CC-BY 2.0 UK)
- Publication Integrity and Ethics (P.I.E.) Guidelines
- Ethical Rules of Disclosure of the Association for Medical Ethics (AME)
- ICMJE Recommendations of the International Committee of Medical Journal Editors (ICMJE)
- Editorial Policy Statements of the Council of Science Editors (CSE)
Tracked/indexed by:
Google Scholar, EZB Nutzeranfragen, RoMEO, CrossRef, CNKI, J-Gate
OAPL (UK) archiving provider: British Library
Our publisher has negotiated a discount for its editors, reviewers and authors to undertake (distant learning- fully online) short courses related to research integrity and publication ethics, law and medical ethics, research governance, good ethical practice, leadership and management. These courses are approved by the Publication Integrity & Ethics.
The Association for Medical Ethics promotes the care of patients absent of any consideration of financial gain or loss based on choice of surgical equipment, implant, manufacturer, hospital or surgery center.
OAPL has adopted the Ethical Rules of Disclosure of the Association for Medical Ethics for all its journals.
A UK-based not-for-profit organization promoting integrity and ethics in the publishing sector through its guidelines and code of conduct.
P.I.E.'s main aim is to pave the way for a better publishing ethical environment that sets out the standards of a good and ethical editorial behaviour.
Whilst P.I.E. (π) promotes editorial freedom, at the same time, it also ensures that this freedom is not violated by editorial misconduct and plagiarism.
OAPL authors may choose to include the
OAPL standard ethics statements
in their submitted articles. It is assumed that all submitted original research studies, research studies, hypothesis, methodologies, short communications, case studies, case reports & case series have been conducted to the highest ethical standards.
Sakurai K, Hoang M, Kim Y, Mathiyakom N, Kim Y. DNA methylation and chromatin dynamics in embryonic stem cell regulation. OA Stem Cells 2014 May 18;2(1):8.
High ImpactOikari LE, Griffiths LR, Haupt LM. The current state of play in human neural stem cell models: what we have learnt from the rodent. OA Stem Cells 2014 Apr 08;2(1):7.
High ImpactRuiz JLM, Levy D, Bydlowski SP. Controversies regarding cancer stem cells. OA Stem Cells 2014 Mar 22;2(1):6.
High ImpactWu XX, Shao JZ, Xiang C. Generation of pancreatic β cells from mesenchymal stem cells to treat type 1 diabetes. OA Stem Cells 2014 Mar 22;2(1):5.
High ImpactDan S, Haibo L, Hong L. Pathogenesis and stem cell therapy for premature ovarian failure. OA Stem Cells 2014 Feb 10;2(1):4.
High ImpactKyurkchiev DS. Cancer stem cells from glioblastoma multiforme: culturing and phenotype. OA Stem Cells 2014 Feb 10;2(1):3.
High ImpactLi Q, Fu X. Immunogenicity and tumorigenicity of human pluripotent stem cells. OA Stem Cells 2014 Jan 18;2(1):2.
High ImpactMontgomery A, Agbay A, Edgar JM, Gabers N, Gomez J, Mohtaram NK, King C, Mitchell A, Rajwani A, Rattray D, Robinson M, Shapka A, Sun L, Wong A, Willerth SM. Combining protein-based biomaterials with stem cells for spinal cord injury repair. OA Stem Cells 2014 Jan 18;2(1):1.
High ImpactTura-Ceide O. Endothelial progenitor cells in chronic obstructive pulmonary disease. OA Stem Cells 2013 Nov 01;1(1):5.
High ImpactAkhtar S. c-kit-positive cardiac stem cells as a potential candidate for heart repair, developments, challenges and future implications. OA Stem Cells 2013 Oct 01;1(1):4.
High ImpactByrne JA. Overcoming clinical hurdles for autologous pluripotent stem cell-based therapies. OA Stem Cells 2013 Sep 01;1(1):3.
High ImpactShi G. Differentiation of human pluripotent stem cells into functional cells. OA Stem Cells 2013 Aug 01;1(1):2.
High ImpactAlmelkar SI, Divate S, Chaudhari S. Peripheral venous blood mononucleated cells have potential to commit to progenitor endothelial cells when exposed to vascular endothelial growth factor. OA Stem Cells 2013 Aug 01;1(1):1.
High ImpactDan S, Haibo L, Hong L. Pathogenesis and stem cell therapy for premature ovarian failure. OA Stem Cells 2014 Feb 10;2(1):4.
High ImpactKyurkchiev DS. Cancer stem cells from glioblastoma multiforme: culturing and phenotype. OA Stem Cells 2014 Feb 10;2(1):3.
High ImpactWu XX, Shao JZ, Xiang C. Generation of pancreatic β cells from mesenchymal stem cells to treat type 1 diabetes. OA Stem Cells 2014 Mar 22;2(1):5.
High ImpactByrne JA. Overcoming clinical hurdles for autologous pluripotent stem cell-based therapies. OA Stem Cells 2013 Sep 01;1(1):3.
High ImpactTura-Ceide O. Endothelial progenitor cells in chronic obstructive pulmonary disease. OA Stem Cells 2013 Nov 01;1(1):5.
High ImpactAkhtar S. c-kit-positive cardiac stem cells as a potential candidate for heart repair, developments, challenges and future implications. OA Stem Cells 2013 Oct 01;1(1):4.
High ImpactLi Q, Fu X. Immunogenicity and tumorigenicity of human pluripotent stem cells. OA Stem Cells 2014 Jan 18;2(1):2.
High ImpactSakurai K, Hoang M, Kim Y, Mathiyakom N, Kim Y. DNA methylation and chromatin dynamics in embryonic stem cell regulation. OA Stem Cells 2014 May 18;2(1):8.
High ImpactRuiz JLM, Levy D, Bydlowski SP. Controversies regarding cancer stem cells. OA Stem Cells 2014 Mar 22;2(1):6.
High ImpactOikari LE, Griffiths LR, Haupt LM. The current state of play in human neural stem cell models: what we have learnt from the rodent. OA Stem Cells 2014 Apr 08;2(1):7.
High ImpactMontgomery A, Agbay A, Edgar JM, Gabers N, Gomez J, Mohtaram NK, King C, Mitchell A, Rajwani A, Rattray D, Robinson M, Shapka A, Sun L, Wong A, Willerth SM. Combining protein-based biomaterials with stem cells for spinal cord injury repair. OA Stem Cells 2014 Jan 18;2(1):1.
High ImpactAlmelkar SI, Divate S, Chaudhari S. Peripheral venous blood mononucleated cells have potential to commit to progenitor endothelial cells when exposed to vascular endothelial growth factor. OA Stem Cells 2013 Aug 01;1(1):1.
High ImpactShi G. Differentiation of human pluripotent stem cells into functional cells. OA Stem Cells 2013 Aug 01;1(1):2.
High ImpactSakurai K, Hoang M, Kim Y, Mathiyakom N, Kim Y. DNA methylation and chromatin dynamics in embryonic stem cell regulation. OA Stem Cells 2014 May 18;2(1):8.
High ImpactOikari LE, Griffiths LR, Haupt LM. The current state of play in human neural stem cell models: what we have learnt from the rodent. OA Stem Cells 2014 Apr 08;2(1):7.
High ImpactRuiz JLM, Levy D, Bydlowski SP. Controversies regarding cancer stem cells. OA Stem Cells 2014 Mar 22;2(1):6.
High ImpactWu XX, Shao JZ, Xiang C. Generation of pancreatic β cells from mesenchymal stem cells to treat type 1 diabetes. OA Stem Cells 2014 Mar 22;2(1):5.
High ImpactDan S, Haibo L, Hong L. Pathogenesis and stem cell therapy for premature ovarian failure. OA Stem Cells 2014 Feb 10;2(1):4.
High ImpactKyurkchiev DS. Cancer stem cells from glioblastoma multiforme: culturing and phenotype. OA Stem Cells 2014 Feb 10;2(1):3.
High ImpactLi Q, Fu X. Immunogenicity and tumorigenicity of human pluripotent stem cells. OA Stem Cells 2014 Jan 18;2(1):2.
High ImpactMontgomery A, Agbay A, Edgar JM, Gabers N, Gomez J, Mohtaram NK, King C, Mitchell A, Rajwani A, Rattray D, Robinson M, Shapka A, Sun L, Wong A, Willerth SM. Combining protein-based biomaterials with stem cells for spinal cord injury repair. OA Stem Cells 2014 Jan 18;2(1):1.
High ImpactTura-Ceide O. Endothelial progenitor cells in chronic obstructive pulmonary disease. OA Stem Cells 2013 Nov 01;1(1):5.
High ImpactAkhtar S. c-kit-positive cardiac stem cells as a potential candidate for heart repair, developments, challenges and future implications. OA Stem Cells 2013 Oct 01;1(1):4.
High ImpactByrne JA. Overcoming clinical hurdles for autologous pluripotent stem cell-based therapies. OA Stem Cells 2013 Sep 01;1(1):3.
High ImpactShi G. Differentiation of human pluripotent stem cells into functional cells. OA Stem Cells 2013 Aug 01;1(1):2.
High ImpactAlmelkar SI, Divate S, Chaudhari S. Peripheral venous blood mononucleated cells have potential to commit to progenitor endothelial cells when exposed to vascular endothelial growth factor. OA Stem Cells 2013 Aug 01;1(1):1.
High ImpactRead about the
OAPL (UK) Code of Conduct for Editors
OAPL (UK) Press Centre- Publishing Director
OAPL (UK) and its journals support the following reporting guidelines for specific study designs:
CONSORT: Consolidated Standards of Reporting Trials
STARD: STAndards for the Reporting of Diagnostic accuracy studies
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses
STROBE: STrengthening the Reporting of OBservational studies in Epidemiology
MOOSE: Meta-analysis of Observational Studies in Epidemiology
MIBBI: Minimum Information for Biological and Biomedical Investigations
ICTRP: International Clinical Trials Registry Platform
PROSPERO: International prospective register of systematic reviews
Copyright © 2013 - 2020 OAPL (UK)